WHWK logo

Whitehawk Therapeutics, Inc. Stock Price

NasdaqCM:WHWK Community·US$97.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

WHWK Share Price Performance

US$2.07
-0.03 (-1.43%)
US$2.07
-0.03 (-1.43%)
Price US$2.07

WHWK Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with moderate risk.

5 Risks
1 Reward

Whitehawk Therapeutics, Inc. Key Details

US$14.4m

Revenue

US$52.6m

Cost of Revenue

-US$38.2m

Gross Profit

-US$22.6m

Other Expenses

-US$15.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.33
-265.55%
-108.58%
0%
View Full Analysis

About WHWK

Founded
2007
Employees
21
CEO
David Lennon
WebsiteView website
ir.whitehawktx.com

Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Recent WHWK News & Updates

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Shares Fly 34% But Investors Aren't Buying For Growth

Oct 17
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Shares Fly 34% But Investors Aren't Buying For Growth

Recent updates

No updates